Develops drugs for cardiovascular diseases.
Dec 2024Revenue C$21.9M/yrExpenses C$22.7M/yr
No trend
Figures by year
When will Medicure be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2024, revenue was C$21.9M and expenses C$22.7M.
| Fiscal year to | Revenue | Expenses | Pre-tax profit |
|---|---|---|---|
| Dec 2024 | C$21.9M | C$22.7M | −C$783K |
| Dec 2023 | C$21.7M | C$22.6M | −C$897K |
| Dec 2022 | C$23.1M | C$21.7M | C$1.39M |
| Dec 2021 | C$21.7M | C$22.5M | −C$759K |
| Dec 2020 | C$11.6M | C$18.5M | −C$6.84M |
| Dec 2019 | C$20.2M | C$39.8M | −C$19.6M |
| Dec 2018 | C$29.1M | C$24.3M | C$4.82M |
| Dec 2017 | C$27.1M | C$24.7M | C$2.44M |
| Dec 2016 | C$29.3M | C$25.5M | C$3.79M |
| Dec 2015 | C$22.1M | C$20.8M | C$1.29M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.